Group One Trading’s Cogent Biosciences COGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.5M Buy
38,900
+17,100
+78% +$631K ﹤0.01% 2343
2025
Q4
$774K Sell
21,800
-27,200
-56% -$765K ﹤0.01% 3123
2025
Q3
$704K Buy
49,000
+43,900
+861% +$520K ﹤0.01% 3355
2025
Q2
$36.6K Buy
5,100
+2,000
+65% +$11.1K ﹤0.01% 5819
2025
Q1
$18.6K Sell
3,100
-9,600
-76% -$75.3K ﹤0.01% 5861
2024
Q4
$99.1K Buy
12,700
+7,800
+159% +$77.7K ﹤0.01% 4533
2024
Q3
$52.9K Sell
4,900
-7,300
-60% -$71.1K ﹤0.01% 4627
2024
Q2
$103K Sell
12,200
-9,800
-45% -$74.3K ﹤0.01% 3940
2024
Q1
$148K Buy
22,000
+15,800
+255% +$97.7K ﹤0.01% 3805
2023
Q4
$36.5K Buy
6,200
+2,400
+63% +$18.4K ﹤0.01% 5308
2023
Q3
$37K Buy
3,800
+3,700
+3,700% +$43.9K ﹤0.01% 5377
2023
Q2
$1.18K Buy
+100
New +$1.15K ﹤0.01% 7223
2022
Q4
Sell
-400
Closed -$6K 7333
2022
Q3
$6K Sell
400
-26,000
-98% -$356K ﹤0.01% 6738
2022
Q2
$238K Buy
+26,400
New +$180K ﹤0.01% 4130

Other funds holding COGT

Group One Trading's COGT Position: Q4 2025 in Review

Group One Trading sold out of Cogent Biosciences (COGT) in Q4 2025, closing a stake of 50,505 shares — an estimated $1.42M sold.

Group One Trading first reported a position in COGT in Q2 2022 and held it in 10 quarters. The position peaked at $725K in Q3 2025. 267 funds tracked by Wall St. Rank hold COGT as of Q4 2025.

  • Group One Trading reported no remaining Cogent Biosciences position as of Q4 2025 after selling out during the quarter.
  • Group One Trading sold 50,505 Cogent Biosciences shares in Q4 2025, an estimated $1.42M.
  • Group One Trading first reported a position in Cogent Biosciences in Q2 2022 and held it in 10 quarters.
  • Group One Trading's Cogent Biosciences position peaked at $725K in Q3 2025.
  • 267 funds tracked by Wall St. Rank held Cogent Biosciences as of Q4 2025.

Based on Group One Trading's 13F filing for Q4 2025, filed 12 Feb 2026.